| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.3B | $7.5B | $7.2B | $10.3B | $12.0B | $11.5B | $2.9B |
| Cost of Revenue | $1.7B | $1.5B | $2.4B | $2.1B | $3.0B | $3.4B | $3.2B | $3.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.2B | $1.1B | $1.8B | $1.6B | $2.2B | $2.2B | $2.1B | $2.0B |
| Operating Income | $-0.0B | $-0.0B | $-0.2B | $0.1B | $0.1B | $2.1B | $0.3B | $0.3B |
| Net Income | $-7.1B | $2.2B | $-4.1B | $1.5B | $0.6B | $-1.6B | $-1.4B | $0.0B |
| EPS (Basic) | $-20.86 | $6.32 | $-9.52 | $3.01 | $1.18 | — | $-2.19 | $0.03 |
| EPS (Diluted) | $-20.86 | $6.11 | $-9.52 | $2.96 | $1.15 | — | $-2.19 | $0.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.6B | $25.4B | $42.1B | $42.9B | $46.9B | $59.1B | $49.0B | $53.2B |
| Current Assets | $3.4B | $3.3B | $5.6B | $6.3B | $5.9B | $4.8B | $10.6B | $4.1B |
| Cash & Equivalents | $2.1B | $1.8B | $1.4B | $1.7B | $0.9B | $1.3B | $8.1B | $1.5B |
| Total Liabilities | $12.7B | $12.9B | $23.1B | $20.3B | $21.3B | $45.8B | $35.8B | $49.0B |
| Current Liabilities | $3.2B | $3.1B | $4.3B | $3.9B | $4.1B | $4.5B | $8.7B | $10.3B |
| Stockholders' Equity | $9.7B | $12.4B | $19.1B | $22.4B | $25.9B | $13.7B | $13.6B | $4.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $2.0B | $2.2B | $2.8B | $3.5B | $4.2B | $4.6B | $6.0B |
| Investing Cash Flow | $-0.9B | $0.7B | $-1.8B | $1.3B | $-5.8B | $-8.9B | $9.3B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-2.3B | $-0.7B | $-3.3B | $-1.5B | $1.1B | $-7.2B | $-6.2B |